The UK’s FCA needs more experience with crypto in order to understand the asset class fully, an expert has warned.
Mark Aruliah, senior policy adviser at blockchain analysis firm Elliptic, who spent a number of years as a technical specialist at the FCA, said he doesn’t see any strong advantages in being in the UK as a crypto firm.
“I’m not saying the UK regulator is in a positive or negative position, I think the jury is out for me,” he said.
Speaking at the recent International Financial Services Forum, Aruliah said he was a supporter of strong regulation and investor protection, but it has to include common sense and pragmatism.
“[There needs to be] more experience within the regulator itself to understand what crypto is,” he said.
He added that the regulation of crypto is different to tradition finance, and on top of that there’s tensions between the legislator, politicians looking at crypto as a benefit to jobs and economic growth, and the natural tendency of the FCA to regulate to a high standard.
The main problem is a lack of dialogue between regulators and crypto firms, he said, which happens in traditional securities markets in the UK but not in crypto.
“That’s the bit that has to change if you want to be conducive to a vibrant sector,” he said.
While cryptocurrencies aren’t regulated as an investment, the asset class was brought under money laundering regulations in 2020 which means certain cryptoasset firms must be registered with the FCA before conducting business.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Files Suit Against Liquor Giant Southern Glazer’s Over Discount Disparities
Dec 12, 2024 by
CPI
Racing Rivals Accuse NASCAR of Retaliation in High-Stakes Antitrust Battle
Dec 12, 2024 by
CPI
Samsung Challenges Indian Antitrust Investigation, Calls Raid “Unlawful”
Dec 12, 2024 by
CPI
European Sites Criticize Google’s Compliance Efforts with DMA
Dec 12, 2024 by
CPI
Banco BPM Overcomes Regulatory Hurdle in $1.7 Billion Bid
Dec 12, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI